missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies BSI-201
Description
- BSI-201, also known as iniparib, can interact with the zinc finger domain of poly(ADP-ribose) polymerase 1 (PARP1) in vitro, but fails to inhibit the enzyme (Patel et al.) The nitroso metabolite of BSI-201 is highly reactive and forms non-specific covalent interactions with many cysteine-containing proteins (Liu et al.) BSI-201 has demonstrated anti-proliferative effects in triple-negative breast cancer cells (Chuang et al.; Yin et al.), and early studies indicated that it may be useful in treating early-stage triple-negative and BRCA1/2 mutation-associated breast cancer (O'Shaughnessy et al. 2009); however, its efficacy was later found to be insignificant (O'Shaughnessy et al.) 2014)
Specifications
Specifications
| CAS | 160003-66-7 |
| Synonym | Iniparib; IND 71677 |
| Quantity | 50 mg |
| Molecular Formula | C7H5IN2O3 |
| Purity | ≥98% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?